Investing.com - Tricida (NASDAQ:TCDA) reported on Monday third quarter earnings that beat analysts' forecasts and revenue that was in line with expectations. Tricida announced...
Tricida (NASDAQ:TCDA) reported Q2 EPS of ($0.49), $0.09 better than the analyst estimate of ($0.58).
For Immediate ReleaseChicago, IL – June 18, 2019 - Stocks in this week’s article Stifel Financial Corp. (NYSE:SF) , Napco Security Technologies, Inc. (NASDAQ:NSSC) ,...
New analyst coverage unearths extensive data on stocks for investors. As analysts are privy to vital information, which is crucial for investment decisions, they are much relied on...
For Immediate ReleaseChicago, IL –April 4, 2019 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts...
Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of veverimer (TRC101), a non-absorbed orally-administered polymer that has completed Phase III trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company was incorporated in 2013 and is headquartered in South San Francisco, California. On January 11, 2023, Tricida, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Strong Sell |
| Technical Indicators | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Strong Sell |
| Summary | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Strong Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 143.96 | 144.25 | 141.90 | +2.10 | +1.48% | 53.60M | NASDAQ | |||
| 48.34 | 48.47 | 47.83 | +0.36 | +0.75% | 12.94M | NASDAQ | |||
| 498.30 | 498.67 | 491.77 | +7.42 | +1.51% | 1.57M | NASDAQ | |||
| 160.27 | 161.42 | 154.76 | +15.84 | +10.97% | 232.88M | NASDAQ | |||
| 20.00 | 20.32 | 19.81 | -0.42 | -2.06% | 47.35M | NYSE | |||
| 28.02 | 28.15 | 26.87 | +2.11 | +8.14% | 9.50M | NASDAQ | |||
| 108.76 | 108.80 | 107.06 | +1.78 | +1.66% | 6.32M | NASDAQ | |||
| 124.65 | 124.73 | 120.80 | +4.28 | +3.56% | 5.80M | NYSE | |||
| 147.30 | 147.51 | 143.30 | +5.80 | +4.10% | 25.35M | NASDAQ | |||
| 126.10 | 127.48 | 124.26 | +1.70 | +1.37% | 906.93K | NYSE | |||
| 5.38 | 5.59 | 5.22 | +0.02 | +0.37% | 6.44M | NYSE | |||
| 8.19 | 8.41 | 8.12 | -0.17 | -2.03% | 6.94M | NYSE | |||
| 114.10 | 114.69 | 112.30 | -2.06 | -1.77% | 1.87M | NYSE | |||
| 27.00 | 27.58 | 26.76 | -0.69 | -2.49% | 45.49K | NYSE | |||
| 443.47 | 473.20 | 438.99 | -19.82 | -4.28% | 3.04M | NYSE |